vivaLAB is an AI driven, digital health company delivering on the significant but unrealised promise of personalised health. The company has built a unique data platform called vivaSOPHIA capturing both consumer real world data (such as lifestyle, nutrition, sleep, exercise, medication & status of the onset of chronic diseases) with muti-omics data (>8,000 biomarkers) from gut microbiome (metagenomics) & metabolic health (metabolomics) testing. vivaLAB collects omics data every 6 months, with the lifestyle data complemented by wearables data collected on a daily basis. Using this unique dataset, vivaLAB is developing multiple AI products: 1. vivaDIETETICA: Digitised “Dietitian” to improve consumer health and wellness 2. vivaBIODIVE: Biomarker identification position to develop next gen health products incl: probio-pharmaceuticals, diagnostics, digital medical devices & therapeutics 3. vivaEARLYGUARD: Patient clustering analytics & development of early disease detection models 4. vivaTREND: Identify wellness trends, nutraceutical and probiotic product development & establish a health “snapshot” of populations & geographic regions The 1st product, vivaDIETETICA, launched in Australia in June 2023 as an MVP of up to 500 consumers is a disruptive DTC offer to the large and growing Vitamins & Dietary Supplement market, with a $3.1b TAM in Aust & $163b globally in 2022, growing at 9% CAGR to 2030. Delivering a personalised wellness plan, this highly differentiated offer empowers consumers with data that is refreshed every 6 months. So as a consumer ages or lifestyle changes, so does vivaDIETETICA’s recommendations maintaining consumer health & wellness This AI product development program represents a large global TAM being addressed either in-house in selected areas, or in partnership. The experienced founding team have built a comprehensive tech stack & compelling consumer offer ready for rapid scaling and international launch in the coming year.
